Page last updated: 2024-09-04

atrasentan and pd 156707

atrasentan has been researched along with pd 156707 in 1 studies

Compound Research Comparison

Studies
(atrasentan)
Trials
(atrasentan)
Recent Studies (post-2010)
(atrasentan)
Studies
(pd 156707)
Trials
(pd 156707)
Recent Studies (post-2010) (pd 156707)
358411081104

Protein Interaction Comparison

ProteinTaxonomyatrasentan (IC50)pd 156707 (IC50)
Endothelin receptor type BHomo sapiens (human)0.417
Endothelin-1 receptorHomo sapiens (human)0.0003
Endothelin receptor type BSus scrofa (pig)0.34

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anzali, S; Christadler, M; Dorsch, D; Fluck, M; Mederski, WW; Osswald, M; Schelling, P; Schmitges, CJ; Wilm, C1

Other Studies

1 other study(ies) available for atrasentan and pd 156707

ArticleYear
Endothelin antagonists: discovery of EMD 122946, a highly potent and orally active ETA selective antagonist.
    Bioorganic & medicinal chemistry letters, 1998, Jul-07, Volume: 8, Issue:13

    Topics: Animals; Biological Availability; Blood Pressure; Endothelin Receptor Antagonists; Endothelin-1; Rats; Receptor, Endothelin A; Swine; Thiazoles

1998